Biologics

期刊简介：Biologics: Targets and Therapy is an international, peer-reviewed, open access journal patho-physiological rationale for, and clinical application of, biologic agents and their biosimilars in the management of autoimmune diseases, cancers, or other pathologies where a molecular target can be identified. Biologics: Targets and Therapy will no longer consider meta-analyses for publication. Specific topics covered by the journal include: • Gene therapy • Cell therapy • Antibody-based therapy • Blood components • Vaccines • Hormones • Cytokines and growth factors • Toxins • Peptides This journal is characterized by the rapid reporting of original research, reviews, basic science, clinical studies and commentaries. The journal does not accept study protocols. The journal will consider case reports only if they make a valuable and original contribution to the literature. When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors’ own data through replication in an original sample.

【译文】《生物制剂：目标与治疗》是一份经过同行评审、开放获取的国际期刊，介绍了生物制剂及其生物仿制药在治疗自身免疫性疾病、癌症或其他可识别分子靶点的病理学方面的病理生理学原理和临床应用。生物制品：目标和治疗将不再考虑发表荟萃分析。该期刊涵盖的具体主题包括： • 基因治疗 • 细胞治疗 • 抗体治疗 • 血液成分 • 疫苗 • 激素 • 细胞因子和生长因子 • 毒素 • 肽 该期刊的特点是快速报道原创研究、评论、基础科学、临床研究和评论。该杂志不接受研究方案。只有当病例报告对文献做出有价值的原创贡献时，该杂志才会考虑它们。在考虑提交利用公开数据的论文时，作者应确保此类研究能够显着丰富知识体系，并且通过在原始样本中复制来使用作者自己的数据进行验证。